These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21503185)

  • 41. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.
    Ekouevi DK; Inwoley A; Tonwe-Gold B; Danel C; Becquet R; Viho I; Rouet F; Dabis F; Anglaret X; Leroy V
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1469-74. PubMed ID: 18160003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of pregnancy to the use of highly active antiretroviral therapy.
    Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
    Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.
    Ekouevi DK; Rouet F; Becquet R; Inwoley A; Viho I; Tonwe-Gold B; Bequet L; Dabis F; Leroy V;
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):755-7. PubMed ID: 15167296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
    Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
    AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considerations for the antiretroviral management of women in 2008.
    Clark R
    Womens Health (Lond); 2008 Sep; 4(5):465-77. PubMed ID: 19072486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
    Aaron E; Kempf MC; Criniti S; Tedaldi E; Gracely E; Warriner A; Kumar R; Bachmann LH
    PLoS One; 2010 Sep; 5(9):e12617. PubMed ID: 20838641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.
    Puthanakit T; Oberdorfer P; Akarathum N; Wannarit P; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2006 Jan; 25(1):53-8. PubMed ID: 16395104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.
    Bussmann H; Wester CW; Wester CN; Lekoko B; Okezie O; Thomas AM; DeGruttola SM; Makhema J; Essex M; Marlink RG
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):269-73. PubMed ID: 17450102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
    Sebitloane HM; Moodley D
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
    Martorell C; Theroux E; Bermudez A; Garb J; Kronschnabel D; Oie K
    Pediatr Infect Dis J; 2010 Oct; 29(10):985. PubMed ID: 20859183
    [No Abstract]   [Full Text] [Related]  

  • 59. Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a review.
    Feller L; Wood NH; Lemmer J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):455-60. PubMed ID: 17604657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.